Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 12/20 | 0.51 |
| ▸ | FNTB | P49356 | 9/20 | 0.51 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.51 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3510870 | 0.90 | FNTA (0.60) | FNTAFNTBPGGT1BGGPS1 | |
| SCHEMBL3510868 | 0.90 | FNTA (0.60) | FNTAFNTBPGGT1BGGPS1 | |
| SCHEMBL10933152 | 0.82 | KMT2A (0.52) | FNTAFNTB | |
| Glycerin SCHEMBL21081941 | 0.77 | FNTA (0.42) | FNTAFNTBPGGT1BGGPS1 | |
| SCHEMBL7616623 | 0.77 | FNTA (0.50) | FNTAFNTBPGGT1BGGPS1 | |
| SCHEMBL16246903 | 0.77 | FNTA (0.43) | FNTAFNTBPGGT1B | |
| SCHEMBL17867409 | 0.77 | KMT2A (0.57) | FNTAFNTB | |
| SCHEMBL134734 | 0.77 | FNTA (0.52) | FNTAFNTBPGGT1BGGPS1 | |
| SCHEMBL19383608 | 0.75 | FNTA (0.55) | FNTAFNTBPGGT1BGGPS1 | |
| SCHEMBL1379701 | 0.75 | FNTA (0.48) | FNTAFNTBPGGT1BGGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150240226-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | BP CORP NORTH AMERICA INC (US) | 2015-08-27 | — | — | US | disclosed |
| US-8962800-B2 | Nucleic acids and proteins and methods for making and using them | BP CORPORATION NORTH AMERICA INC. (US) | 2015-02-24 | — | — | US | disclosed |
| US-20120266329-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | BP CORPORATION NORTH AMERICA INC. (US) | 2012-10-18 | — | — | US | disclosed |
| US-8119385-B2 | Nucleic acids and proteins and methods for making and using them | BP CORPORATION NORTH AMERICA INC. (US) | 2012-02-21 | — | — | US | disclosed |
| US-20110296543-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | THE UNIVERSITY OF CALIFORNIA (US) | 2011-12-01 | — | — | US | disclosed |
| US-20100011456-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | VERENIUM CORPORATION (US) | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150240226-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | POLN, POLM, POLI | FNTA 1881/4885FNTB 1111/4885PGGT1B 3501/4885 |
| US-20120266329-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | POLN, POLM, POLI | FNTA 1881/4885FNTB 1111/4885PGGT1B 3501/4885 |
| US-20100011456-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | POLN, POLM, POLI | FNTA 1881/4885FNTB 1111/4885PGGT1B 3501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.